BCMA, or B-cell maturation antigen is crucial in MM pathogenesis, largely due to its interactions with the ligands APRIL (a proliferation-inducing ligand) and BAFF (B-cell activating factor) [142–144]. Here, TNFSF13B is linked to Miyoshi myopathy.